Canada Markets closed

Aridis Pharmaceuticals, Inc. (ARDS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.31000.0000 (0.00%)
At close: 04:00PM EDT
2.3100 0.00 (0.00%)
After hours: 05:17PM EDT

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • T
    TRADING SNIPER
    I give management credit they did drop the announcement at the perfect time too bad the market did not respond to this :(
  • s
    steve
    UAB is one of the best hospitals in the World. If they are funding Aridis research something is there.
  • T
    TRADING SNIPER
    Good effort into close folks hope the after hours action holds
  • B
    BG
    Let's go Neil!
  • R
    Russ
    ARDS is going UP! Get ready for major announcement
  • N
    Neil
    to whom it may concern.... by the end of this week that's going to be the sorryest 5000 shares that you sold at a buck 24 in your life just remember that😜👁️
  • B
    BG
    Gaps closed Uncle Neil
  • R
    RPMcKenna1976
    Great week last week, up %118, was looking good today until about two p.m. but I am sure there was some profit taking today. It's to be expected. Was considering the same myself, but held tight. Our biggest goal is to stay above $2.00 to maintain NASDAQ listing.
  • R
    Ritz
    How far it will go? Any guess?
  • B
    BG
    I was gone for a week but there has been some happenings over the last week. Another article posted about their monoclonal. Search "Demonstration of a potent, universal coronavirus monoclonal antibody therapy for all COVID-19 variants." and you will be able to see. Also they updates their trial of AR-320 here at https://www.clinicaltrials.gov/ct2/show/NCT05331885?lead=Aridis&draw=2&rank=1. It now has a estimated study start date of August. I'm guessing that will be paired with AR-301 results. Also there was a nice symmetrical continuation triangle on July 20th. Neil has it right when he said she'll be moving soon. Hang in there guys.
    A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2 - Full Text View.
    A Human Monoclonal Antibody Against Staphylococcus Aureus Alpha Toxin in Mechanically Ventilated Adult Subjects - 2 - Full Text View.
    www.clinicaltrials.gov
  • a
    amit
    squeez in progres here. lets go
  • F
    Flavio
    I am so tired of ARDS doing nothing all day. Can you move??? I have been reading (http://Achieverspot.tech) for a month now and the stocks there actually go!
  • B
    BG
    Hopefully the EOD and EOW dump isn't that bad and we can hold above $1.70. That would be amazing.
  • T
    TRADING SNIPER
    I truly truly hope management was slow rolling that meeting to trap a large amount of short sellers before dropping news report in the near term! Would create the PERFECT STORM!!
  • R
    RPMcKenna1976
    This should help bring some things to light for investors and potential investors. Interview from redchip stocks: https://m.youtube.com/watch?v=wfAbLpY6mfg

    From what I am gathering, results from AR-301 may take up to 4th quarter to be available. Looks like HUGE potential for those willing to go the long run.
  • R
    RPMcKenna1976
    Interesting pre-market, no bid, $4.00 ask, last sale $2.02...
  • N
    Neil
    breakout should come next week not this week based on my calculations of stocks in this price range as well as laws of probability... today of course speaks for itself another Gap up on low volume which will need to be filled patience my friends patience for now all eyes on Sidu could be the next millionaire Maker 3 and 1/2 billion dollar contract with NASA over 10 years grabbed it under three and grabbing more as we speak 👁️🏌️
  • b
    blockbuster
    (RVPH) $0.80---MC $12 mil --Potential Blockbuster Drug in Phase 3 (Schizophrenia) nearing data readout and multiple Phase 2 ready programs also targeting multi billion dollar markets = one of the cheapest biotech gem
    https://revivapharma.com/wp-content/uploads/2015/03/Pipeline_01.png

    #####